Jaap Goudsmit
Overview
Explore the profile of Jaap Goudsmit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
9838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beukenhorst A, Frallicciardi J, Rice K, Koldijk M, Moreira de Mello J, Klap J, et al.
Sci Rep
. 2024 Feb;
14(1):3818.
PMID: 38360813
Avian A(H5N1) influenza virus poses an elevated zoonotic threat to humans, and no pharmacological products are currently registered for fast-acting pre-exposure protection in case of spillover leading to a pandemic....
2.
Akeju O, Mens M, Warmerdam R, Dijkema M, van den Biggelaar A, Franke L, et al.
J Gerontol A Biol Sci Med Sci
. 2024 Feb;
79(4).
PMID: 38305578
Longevity and disease-free survival are influenced by a combination of genetics and lifestyle. Biological age (BioAge), a measure of aging based on composite biomarkers, may outperform chronological age in predicting...
3.
Beukenhorst A, Koch C, Hadjichrysanthou C, Alter G, de Wolf F, Anderson R, et al.
Eur J Epidemiol
. 2023 Feb;
38(3):237-242.
PMID: 36738380
Neither vaccination nor natural infection result in long-lasting protection against SARS-COV-2 infection and transmission, but both reduce the risk of severe COVID-19. To generate insights into optimal vaccination strategies for...
4.
Hadjichrysanthou C, Beukenhorst A, Koch C, Alter G, Goudsmit J, Anderson R, et al.
Infect Dis Ther
. 2022 Oct;
11(6):2287-2296.
PMID: 36309921
Introduction: The COVID-19 pandemic has demonstrated that there is an unmet need for the development of novel prophylactic antiviral treatments to control the outbreak of emerging respiratory virus infections. Passive...
5.
Waziry R, Hofman A, Ghanbari M, Tiemeier H, Ikram M, Viswanathan A, et al.
J Stroke Cerebrovasc Dis
. 2022 Jun;
31(8):106568.
PMID: 35749936
Background And Objectives: successful interventions to prevent cerebrovascular disease and stroke require early identification of persons at risk before clinical manifestation of disease. The literature remains to be sparse on...
6.
Wu J, Yaqub A, Ma Y, Koudstaal W, Hofman A, Ikram M, et al.
Sci Rep
. 2021 Aug;
11(1):15929.
PMID: 34354164
Application of biological age as a measure of an individual´s health status offers new perspectives into extension of both lifespan and healthspan. While algorithms predicting mortality and most aging-related morbidities...
7.
Goudsmit J, van den Biggelaar A, Koudstaal W, Hofman A, Koff W, Schenkelberg T, et al.
Eur J Epidemiol
. 2021 Jun;
36(7):753-762.
PMID: 34117979
The Human Immunomics Initiative (HII), a joint project between the Harvard T.H. Chan School of Public Health and the Human Vaccines Project (HVP), focuses on studying immunity and the predictability...
8.
Ma Y, Zhou J, Kavousi M, Lipsitz L, Mattace-Raso F, Westerhof B, et al.
Alzheimers Dement
. 2021 Apr;
17(7):1134-1144.
PMID: 33860609
Introduction: We hypothesized that subclinical disruption in blood pressure (BP) dynamics, captured by lower complexity and higher variability, may contribute to dementia risk, above and beyond BP levels. Methods: This...
9.
Terzikhan N, Hofman A, Goudsmit J, Ikram M
Eur J Epidemiol
. 2021 Feb;
36(3):319-324.
PMID: 33634346
Initial results from various phase-III trials on vaccines against SARS-CoV-2 are promising. For proper translation of these results to clinical guidelines, it is essential to determine how well the general...
10.
Koff W, Schenkelberg T, Williams T, Baric R, McDermott A, Cameron C, et al.
Sci Transl Med
. 2021 Feb;
13(579).
PMID: 33536277
Development of safe and effective COVID-19 vaccines is a global priority and the best hope for ending the COVID-19 pandemic. Remarkably, in less than 1 year, vaccines have been developed...